Logo image
A reduction in antenatal steroid dose was associated with reduced cardiac dysfunction in a Sheep model of pregnancy
Journal article   Open access   Peer reviewed

A reduction in antenatal steroid dose was associated with reduced cardiac dysfunction in a Sheep model of pregnancy

Yusaku Kumagai, Matthew W Kemp, Haruo Usuda, Tsukasa Takahashi, Yuki Takahashi, Hirotaka Hamada, Augusto F Schmidt, Takushi Hanita, Shimpei Watanabe, Shinichi Sato, …
Reproductive sciences (Thousand Oaks, Calif.), Vol.30(11), pp.3222-3234
2023
PMID: 37264260
pdf
Published1.62 MBDownloadView
CC BY V4.0 Open Access
url
https://doi.org/10.1007/s43032-023-01264-2View
Published (Version of Record) Open

Abstract

Hypertrophy of cardiomyocytes Antenatal corticosteroid Betamethasone phosphate Cardiac function Fetal programming Developmental origins of health and disease (DOHaD)
Despite widespread use, dosing regimens for antenatal corticosteroid (ACS) therapy are poorly unoptimized. ACS therapy exerts a programming effect on fetal development, which may be associated with an increased risk of cardiovascular disease. Having demonstrated that low-dose steroid therapy is an efficacious means of maturing the preterm lung, we hypothesized that a low-dose steroid exposure would exert fewer adverse functional and transcriptional changes on the fetal heart. We tested this hypothesis using low-dose steroid therapy (10 mg delivered to the ewe over 36 h via constant infusion) and compared cardiac effects with those of a higher dose treatment (30 mg delivered to the ewe over 24 h by intramuscular injection; simulating currently employed clinical ACS regimens). Fetal cardiac function was assessed by ultrasound on the day of ACS treatment initiation. Transcriptomic analyses were performed on fetal myocardial tissue. Relative to saline control, fetuses in the higher-dose clinical treatment group had significantly lower ratios between early diastolic ventricular filling and ventricular filling during atrial systole, and showed the differential expression of myocardial hypertrophy-associated transcripts including βMHC, GADD45γ, and PPARγ. The long-term implications of these changes remain unstudied. Irrespective, optimizing ACS dosing regimens to maximize respiratory benefit while minimizing adverse effects on key organ systems, such as the heart, offers a means of improving the acute and long-term outcomes associated with this important obstetric therapy.

Details

UN Sustainable Development Goals (SDGs)

This output has contributed to the advancement of the following goals:

#15 Life on Land

Metrics

16 File views/ downloads
46 Record Views

InCites Highlights

These are selected metrics from InCites Benchmarking & Analytics tool, related to this output

Collaboration types
Domestic collaboration
International collaboration
Citation topics
1 Clinical & Life Sciences
1.72 Obstetrics & Gynecology
1.72.924 Preterm Birth Causes
Web Of Science research areas
Obstetrics & Gynecology
Reproductive Biology
ESI research areas
Clinical Medicine
Logo image